Management of Pain Possible for Childhood Vaccinations

Published Online: Thursday, August 16, 2012
Follow Pharmacy_Times:
Pain associated with childhood vaccination is currently undertreated, even though there are number of pain-relieving strategies that could be employed. Many health care providers argue, however, that they are currently too pressed for time to implement these strategies.

To determine whether there was enough time available for pain management within each vaccination appointment, researchers at the University of Toronto conducted a prospective naturalistic study at 8 urban outpatient primary care clinics and published their results in the March-April 2012 edition of the Clinical Journal of Pain. The researchers tracked the waiting time of children in 405 appointments from clinic arrival to first vaccine administered.

Their results showed that the mean wait time until first vaccination was 41.6 minutes, with a range from 7 to 132 minutes. There was a statistically significant difference among the clinics for wait times, which explains the wide range of data. These results suggest that, contrary to the perception of some health care providers, there is adequate time available to implement pain management strategies for children undergoing vaccination.

The researchers note that health care providers and parents should be educated regarding the benefits of pain management interventions and how to put evidence-based strategies into practice.

To read more articles in this watch, click:
Muscle Relaxants in Rheumatoid Arthritis
Self-Management Demonstrated in Migraine Patients


Related Articles
Updated REMS attempts to stem the flow of extended-release, long-acting opioids to addicts while ensuring patients in severe pain retain access.
Vast majority of parents are opting for their young children to receive potentially lifesaving vaccines despite the controversy surrounding their right to refuse such immunizations.
A University of Kentucky pharmacy professor has developed a nasal spray of naloxone (Narcan) to treat potentially fatal overdoses from heroin and prescription opioids.
Drugs that contain hydrocodone will be moved to a more restrictive category of the Controlled Substances Act.
Latest Issues
$auto_registration$